115 related articles for article (PubMed ID: 1310581)
1. Irreversible inhibition of human cytomegalovirus replication by topoisomerase II inhibitor, etoposide: a new strategy for the treatment of human cytomegalovirus infection.
Huang ES; Benson JD; Huong SM; Wilson B; van der Horst C
Antiviral Res; 1992 Jan; 17(1):17-32. PubMed ID: 1310581
[TBL] [Abstract][Full Text] [Related]
2. Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome.
Benson JD; Huang ES
J Virol; 1988 Dec; 62(12):4797-800. PubMed ID: 2846890
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.
Markovits J; Pommier Y; Kerrigan D; Covey JM; Tilchen EJ; Kohn KW
Cancer Res; 1987 Apr; 47(8):2050-5. PubMed ID: 3030540
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
[TBL] [Abstract][Full Text] [Related]
5. Amiloride inhibition of human cytomegalovirus replication.
Fons M; Nokta M; Cerruti-Sola S; Albrecht T
Proc Soc Exp Biol Med; 1991 Jan; 196(1):89-96. PubMed ID: 1845780
[TBL] [Abstract][Full Text] [Related]
6. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Neyts J; De Clercq E
Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
[TBL] [Abstract][Full Text] [Related]
7. [Influence of membrane-active polyanions on various stages of the human cytomegalovirus life cycle in vitro].
Pavlova MV; Fedorova NE; Serbin AV; Klimova EV; Karaseva EN; Golyshev SA; Kushch AA
Antibiot Khimioter; 2008; 53(11-12):3-10. PubMed ID: 19441649
[TBL] [Abstract][Full Text] [Related]
8. Everolimus delayed and suppressed cytomegalovirus DNA synthesis, spread of the infection, and alleviated cytomegalovirus infection.
Tan L; Sato N; Shiraki A; Yanagita M; Yoshida Y; Takemura Y; Shiraki K
Antiviral Res; 2019 Feb; 162():30-38. PubMed ID: 30543830
[TBL] [Abstract][Full Text] [Related]
9. Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication.
He R; Park K; Cai H; Kapoor A; Forman M; Mott B; Posner GH; Arav-Boger R
Antimicrob Agents Chemother; 2012 Jul; 56(7):3508-15. PubMed ID: 22547612
[TBL] [Abstract][Full Text] [Related]
10. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.
Waldman WJ; Knight DA; Lurain NS; Miller DM; Sedmak DD; Williams JW; Chong AS
Transplantation; 1999 Sep; 68(6):814-25. PubMed ID: 10515382
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA
Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713
[TBL] [Abstract][Full Text] [Related]
12. Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication.
Cohen T; Williams JD; Opperman TJ; Sanchez R; Lurain NS; Tortorella D
J Virol; 2016 Dec; 90(23):10715-10727. PubMed ID: 27654292
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
Epstein RJ; Smith PJ
Cancer Res; 1988 Jan; 48(2):297-303. PubMed ID: 2825970
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytomegalovirus replication by smooth-muscle relaxing agents.
Albrecht T; Lee CH; Speelman DJ; Steinsland OS
Proc Soc Exp Biol Med; 1987 Oct; 186(1):41-6. PubMed ID: 2819886
[TBL] [Abstract][Full Text] [Related]
15. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.
Holm C; Covey JM; Kerrigan D; Pommier Y
Cancer Res; 1989 Nov; 49(22):6365-8. PubMed ID: 2553254
[TBL] [Abstract][Full Text] [Related]
16. Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers.
Arav-Boger R; He R; Chiou CJ; Liu J; Woodard L; Rosenthal A; Jones-Brando L; Forman M; Posner G
PLoS One; 2010 Apr; 5(4):e10370. PubMed ID: 20442781
[TBL] [Abstract][Full Text] [Related]
17. 1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication.
Akanitapichat P; Lowden CT; Bastow KF
Antiviral Res; 2000 Feb; 45(2):123-34. PubMed ID: 10809021
[TBL] [Abstract][Full Text] [Related]
18. Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL.
Alam Z; Al-Mahdi Z; Zhu Y; McKee Z; Parris DS; Parikh HI; Kellogg GE; Kuchta A; McVoy MA
Antiviral Res; 2015 Feb; 114():86-95. PubMed ID: 25499125
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity and mechanism of action of ganciclovir.
Matthews T; Boehme R
Rev Infect Dis; 1988; 10 Suppl 3():S490-4. PubMed ID: 2847285
[TBL] [Abstract][Full Text] [Related]
20. Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle.
Gardner TJ; Cohen T; Redmann V; Lau Z; Felsenfeld D; Tortorella D
Antiviral Res; 2015 Jan; 113():49-61. PubMed ID: 25446405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
